MERCURY LABORATORIES
Back to Balance Sheet
|
MERCURY LABORATORIES Last 5 Year Total Current Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹16 Cr | ₹16 Cr | ₹19 Cr | ₹15 Cr | ₹17 Cr |
What is the latest Total Current Liabilities ratio of MERCURY LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹16 Cr |
Mar2022 | ₹16 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹15 Cr |
Mar2019 | ₹17 Cr |
How is Total Current Liabilities of MERCURY LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹16 Cr | 4.32 | |
Mar2022 | ₹16 Cr | -16.39 | |
Mar2021 | ₹19 Cr | 25.02 | |
Mar2020 | ₹15 Cr | -10.95 | |
Mar2019 | ₹17 Cr | - |
Compare Total Current Liabilities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹120.1 Cr | -5.4% | 6.4% | 25.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,025.0 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,299.0 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
CIPLA | ₹132,316.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,579.0 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,092.0 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -5.4% |
6.4% |
25.9% |
SENSEX | 0.3% |
3% |
23.3% |
You may also like the below Video Courses